Aug 11 (Reuters) - Active Biotech Ab ACTI.ST :
* Q2 operating loss 14.5 million SEK (-70)
* Q2 net sales 3.9 million SEK (3.2)
* Says operations are progressing according to plan pending the Phase 3 results for laquinimod in the first half of 2017 Source text for Eikon: ID:nHUG2cQ36f Further company coverage: ACTI.ST